Dimetapp hasn’t been taken off the market. It’s just that the FDA warned that inexact dosing could lead to an overdose in children; GSK has not reported any adverse effects so far.
The recalled lots of Robitussin and Dimetapp were distributed nationwide between Feb. 5 and June 3 and carry the GSK and Pfizer brand names on their labels.